I would like to add a comment on this topic. We also hear that technologies have changed. I believe it was in the same letter that my colleague Mr. Poilievre mentioned. It is said that, among other things, it is due to your organization's investment in research to alleviate the effects of diabetes on daily life, technologies are now making treatment time less than 14 hours possible.
What are your thoughts on this comment? Is there a way to address this situation? If the technology has changed, maybe the criteria are no longer adequate.